Well....I don't think today's news is it. The end of the NR imo says it all:
The Company continues to review these and additional findings for potential peer reviewed journal publications.
Maybe this was the reason for all the buying Friday, but I have my doubts. I still think something much bigger is waiting in the wings....an orphan disease announcement or FDA approval. If we start trading consitently over $2USD then I'll add a Naz listing to the mix.